Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of Obstetrics and Gynecology
Journal of Gynecologic Oncology · 2023
DOI: 10.3802/jgo.2023.34.e38 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Gynecologic Oncology, 2023. Verfasst von Kimio Ushijima und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Kurume University School of Medicine, Fukuoka, Japan. Hauptthemen laut MEDLINE: Endometrial Hyperplasia, Genital Neoplasms, Female, Gynecology, Fertility Preservation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVE: The objective of this study was to examine the current trends in fertility-sparing (FS) treatment for young atypical endometrial hyperplasia (AEH) and endometrial cancer (EC) patients in Japan. METHODS: This study was conducted by the Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology (JSOG) in the 2017-2018 fiscal year. A nationwide, retrospective questionnaire-style survey-as performed. We collected the data of 413 patients from 102 JSOG gynecological cancer registered institutions. RESULTS: FS treatment was performed with medroxyprogesterone (MPA) (87.2%) or MPA + metformin (11.6%). Pathological complete remission (CR) after initial treatment was achieved in 78.2% of patients. The significant clinicopathological factors correlated to CR after initial treatment were histology (AEH vs. endometrioid carcinoma grade 1 [ECG1]), body mass index (BMI) (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Kurume University School of Medicine, Fukuoka, Japan.
- Department of Obstetrics and Gynecology, Kurume University School of Medicine, Fukuoka, Japan. naotakehouston@gmail.com.
- Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
- Department of Reproductive Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
- Department of Obstetrics and Gynecology, School of Medicine, Dokkyo Medical University, Tochigi, Japan.
- Department of Obstetrics and Gynecology, Tokai University School of Medicine, Kanagawa, Japan.
ORCID-Profile: Kimio Ushijima, Naotake Tsuda, Wataru Yamagami, Akira Mitsuhashi, Mikio Mikami, Nobuo Yaegashi, Takayuki Enomoto
Zitieren
APA
Ushijima, K., Tsuda, N., Yamagami, W., Mitsuhashi, A., Mikami, M., Yaegashi, N., & Enomoto, T. (2023). Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of Obstetrics and Gynecology. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2023.34.e38
Vancouver
Ushijima K, Tsuda N, Yamagami W, Mitsuhashi A, Mikami M, Yaegashi N, et al. Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of Obstetrics and Gynecology. Journal of Gynecologic Oncology. 2023. doi:10.3802/jgo.2023.34.e38
BibTeX
@article{Ushijima2023,
author = {Ushijima, Kimio and Tsuda, Naotake and Yamagami, Wataru and Mitsuhashi, Akira and Mikami, Mikio and Yaegashi, Nobuo and Enomoto, Takayuki},
title = {Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of Obstetrics and Gynecology},
journal = {Journal of Gynecologic Oncology},
year = {2023},
doi = {10.3802/jgo.2023.34.e38}
}
EUVIMED